NCT00574145

Brief Summary

RATIONALE: Healing touch therapy may be effective in lessening fatigue in women with breast cancer who are undergoing radiation therapy. PURPOSE: This randomized clinical trial is studying how well healing touch works in treating fatigue in women undergoing radiation therapy for breast cancer.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
44

participants targeted

Target at P25-P50 for not_applicable breast-cancer

Timeline
Completed

Started Feb 2007

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2007

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

December 14, 2007

Completed
3 days until next milestone

First Posted

Study publicly available on registry

December 17, 2007

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2009

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2009

Completed
3.4 years until next milestone

Results Posted

Study results publicly available

September 6, 2012

Completed
Last Updated

September 6, 2012

Status Verified

August 1, 2012

Enrollment Period

2.2 years

First QC Date

December 14, 2007

Results QC Date

March 15, 2012

Last Update Submit

August 4, 2012

Conditions

Keywords

fatiguedepressionpsychosocial effects of cancer and its treatmentstage I breast cancerstage II breast cancerstage IIIA breast cancerstage IIIB breast cancerstage IIIC breast cancerrecurrent breast cancer

Outcome Measures

Primary Outcomes (1)

  • Fatigue Using the Brief Fatigue Inventory (BFI)

    9-items with an 11-point rating scale measures intensity of fatigue (3 items, 0 = no fatigue to 10 = fatigue as bad as you can imagine) and interference of fatigue on daily life (6 items, 0 = does not interfere to 10 = completely interferes. Each participant's score is summed with a possible minimum score of 0 and a possible maximum score of 90. A mean score was then determined.

    6 weeks

Secondary Outcomes (2)

  • Quality of Life as Measured by the Functional Assessment of Cancer Therapy-Breast Form (FACT-B)

    baseline and 6 weeks

  • Intensity of Anxiety and Depression

    baseline and off-radiation at 5 to 7 weeks

Study Arms (2)

Radiotherapy/Supportive Care (A)

EXPERIMENTAL

Patients receive radiotherapy and healing touch therapy from a healing touch therapist once a week for the duration of their radiotherapy

Procedure: Bio-field energy therapyProcedure: fatigue assessment and managementProcedure: psychosocial assessment and careProcedure: quality-of-life assessmentProcedure: therapeutic touch

Control ARM (B)

SHAM COMPARATOR

Patients receive radiotherapy and sham healing touch therapy from a sham healing touch therapist once a week for the duration of their therapy

Procedure: fatigue assessment and managementProcedure: psychosocial assessment and careProcedure: quality-of-life assessment

Interventions

Practitioner's hands to influence the human energy field surrounding the patient's body.

Also known as: biofield therapy
Radiotherapy/Supportive Care (A)

duration

Control ARM (B)Radiotherapy/Supportive Care (A)

duration

Control ARM (B)Radiotherapy/Supportive Care (A)

duration

Control ARM (B)Radiotherapy/Supportive Care (A)

Practitioner's hands to influence the human energy field surrounding the patient's body

Radiotherapy/Supportive Care (A)

Eligibility Criteria

Age21 Years - 75 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Histologically proven breast cancer
  • Receiving post lumpectomy or post mastectomy radiation therapy (RT)
  • Eastern Cooperative Oncology Group performance status of 0, 1 or 2
  • Prescribed a minimum of 5 weeks of RT
  • Between the ages of 21 and 75
  • Able to speak English.
  • Provides written informed consent

You may not qualify if:

  • Documented active psychiatric illness
  • Documented cognitive impairment that would preclude the ability to provide informed consent.
  • Stage IV breast cancer
  • Receiving concurrent chemotherapy and RT

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Vanderbilt-Ingram Cancer Center - Cool Springs

Nashville, Tennessee, 37064, United States

Location

Vanderbilt-Ingram Cancer Center at Franklin

Nashville, Tennessee, 37064, United States

Location

Vanderbilt-Ingram Cancer Center

Nashville, Tennessee, 37232-6838, United States

Location

Related Publications (1)

  • FitzHenry F, Wells N, Slater V, Dietrich MS, Wisawatapnimit P, Chakravarthy AB. A randomized placebo-controlled pilot study of the impact of healing touch on fatigue in breast cancer patients undergoing radiation therapy. Integr Cancer Ther. 2014 Mar;13(2):105-13. doi: 10.1177/1534735413503545. Epub 2013 Oct 7.

MeSH Terms

Conditions

Breast NeoplasmsDepressionFatigue

Interventions

TherapeuticsPsychiatric RehabilitationTherapeutic Touch

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue DiseasesBehavioral SymptomsBehaviorSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

RehabilitationHealth ServicesHealth Care Facilities Workforce and ServicesMind-Body TherapiesComplementary TherapiesSpiritual Therapies

Results Point of Contact

Title
Nancy Wells, DNSc., R.N
Organization
Vanderbilt-Ingram Cancer Center

Study Officials

  • Nancy Wells, DNSc, RN

    Vanderbilt-Ingram Cancer Center

    PRINCIPAL INVESTIGATOR
  • Fern Fitzhenry, PhD, RN

    Vanderbilt-Ingram Cancer Center

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Professor of Nursing; Director, VUMC Nursing

Study Record Dates

First Submitted

December 14, 2007

First Posted

December 17, 2007

Study Start

February 1, 2007

Primary Completion

April 1, 2009

Study Completion

April 1, 2009

Last Updated

September 6, 2012

Results First Posted

September 6, 2012

Record last verified: 2012-08

Locations